Unraveling the MFR Protein: Key Functions, Research Frontiers and ANT BIO PTE. LTD. Product Enablement

Unraveling the MFR Protein: Key Functions, Research Frontiers and ANT BIO PTE. LTD. Product Enablement

ANT BIO PTE. LTD. is a leading enterprise specializing in life science reagents, whose core product portfolio covers antibodies, recombinant proteins, assay kits and general life science reagents. The company owns three professional sub-brands with distinct positioning: Absin focuses on general reagents and assay kits, Starter is dedicated to high-quality antibodies, and UA specializes in recombinant proteins. This article delves into the macrophage fusion receptor (MFR) protein, a cutting-edge research hotspot in life science, elaborating on its structural characteristics, biological functions and innovative biotechnological applications, while presenting how ANT BIO PTE. LTD.’s products provide solid experimental support for MFR protein research.

1. Concept of MFR Protein

Macrophage Fusion Receptor (MFR), also designated as SIRPα or CD172a in animal systems, is a vital transmembrane protein family with divergent structural and functional traits across the animal and plant kingdoms. In animals, it acts as a core regulatory molecule in the immune system, while plant MFR (MORF4-related factor) exerts pivotal roles in gene expression modulation and disease resistance signal transduction. With the rapid development of multi-omics, artificial intelligence and precision gene editing technologies, MFR protein research has moved beyond single-molecule functional analysis, stepping into a new era of integrative innovation at the systems biology level, becoming a research focus bridging biomedical research and agricultural science.

2. Research Frontiers of MFR Protein

Recent research on MFR protein has achieved remarkable breakthroughs in animal immunoregulation, plant disease resistance and interdisciplinary biotechnological innovation, uncovering its multi-dimensional biological functions and laying a foundation for translational applications in medicine and agriculture.

2.1 Structural Traits and Animal Immunoregulatory Functions of MFR Protein

As a transmembrane protein family central to the animal immune system, MFR protein features a multi-subunit architecture: its extracellular domain contains immunoglobulin-like (Ig-like) motifs, and the intracellular region harbors immunoreceptor tyrosine-based inhibitory motifs (ITIM). This unique structural design endows MFR with the ability to mediate the "Don't Eat Me" immune signal via binding to its ligand CD47.

Upon the combination of CD47 with MFR on the macrophage surface, the ITIM motifs recruit SHP-1/SHP-2 phosphatases, which in turn inhibit the phosphorylation of macrophage activation receptors, thus preventing the phagocytic clearance of normal healthy cells. Tumor cells have evolved to hijack this regulatory mechanism by upregulating CD47 expression—for instance, the CD47 level in acute myeloid leukemia cells is 4.8-fold higher than that in normal hematopoietic stem cells, resulting in a 72% reduction in the phagocytic index of macrophages.

Beyond immune regulation, MFR protein also participates in the development of the nervous system: it modulates the aggregation of postsynaptic density protein 95 (PSD-95) in hippocampal neurons through interaction with NCAM1, and hippocampal synaptic density is reduced by 35% in MFR gene knockout animal models, indicating its indispensable role in synaptic development and plasticity.

Schematic diagram illustrating the interaction between MFR (SIRPα) and CD47, and the regulatory mechanism of this binding on macrophage phagocytosis, as well as the intervention effects of related antibodies and fusion proteins on the MFR-CD47 signaling axis.

2.2 Unique Biological Functions and Disease Resistance Mechanisms of Plant MFR Protein

In plant research, the functional exploration of MFR (MORF4-related factor) proteins has made significant progress in recent years, and their biological functions are completely different from those in animals—plant MFR proteins mainly mediate nuclear gene expression regulation and plant disease resistance signal transduction.

Experimental evidence confirms that plant MFR proteins can activate the transcription of disease resistance-associated genes (e.g., PR protein genes) by binding to specific DNA cis-elements or interacting with transcription factor complexes. For example, MFR homologs in Arabidopsis thaliana can rapidly sense pathogen-associated molecular patterns (PAMPs), triggering reactive oxygen species (ROS) burst and callose deposition in plant cells. These cellular responses effectively enhance the physical barrier function of plant cell walls, thereby inhibiting the invasion and colonization of pathogenic microorganisms.

A notable characteristic of plant MFR proteins is their dual regulatory mode: under normal non-stress conditions, they inhibit the expression of growth-related genes to maintain metabolic balance; when plants are infected by pathogens, this inhibitory effect is relieved, and the proteins activate the plant defense response pathway. This "molecular switch" regulatory mechanism provides a novel molecular target for the genetic improvement of crops, offering a feasible approach to breeding new crop varieties with both enhanced disease resistance and high yield.

2.3 Biotechnological Innovations Driven by MFR Protein Research

The in-depth exploration of MFR protein’s structure and function has spurred a series of innovative applications in biotechnology, covering precision medicine, tumor nanobiotechnology and autoimmune disease therapy, with outstanding performance in preclinical research and experimental validation.

2.3.1 Advances in Drug Development and Precision Medicine

Based on the structural and functional characteristics of MFR protein, researchers have developed a variety of novel technical platforms and detection tools, whose core performance indicators have reached high levels of clinical and experimental application value, as shown in Table 1:

 

Technical Field

Action Mechanism

Key Performance Indicators

MFR-DTA Prediction Model

Integrates Transformer neural network architecture and protein-protein interaction networks, with input of MFR protein sequence features (hydrophobicity, charge distribution, etc.)

Prediction accuracy: 92.3%; ROC-AUC value: 0.96

FMR-AA Fluorescent Protein

Site-directed mutagenesis (V158F/T203Y) enhances the π-π stacking effect of the protein, eliminating pH-sensitive proton transfer processes

Fluorescence stability increased by 5 times (stable fluorescence emission at pH 4.5-8.0)

MFR-CD47 Detection Kit

Establishes a double-antibody sandwich ELISA method, using biotin-labeled MFR protein extracellular domain (amino acid residues 1-210) as the capture probe

Detection limit: 12 pg/mL; linear detection range: 0.05-10 ng/mL

2.3.2 Innovative Applications in Nanobiotechnology

2.3.2.1 Tumor-Targeted Drug Delivery System

MFR-modified PLGA nanoparticles (particle size: 120±15 nm) are designed for tumor-targeted drug delivery, and their preclinical experimental performance shows excellent targeting ability, drug release efficiency and biological safety:

  • Targeting efficiency: In tumor-bearing mouse models, the tumor tissue accumulation of MFR-modified nanoparticles is 3.8 times higher than that of non-targeted nanoparticles (detected by 24-hour PET-CT imaging);
  • Stimuli-responsive drug release: The acidic microenvironment of tumor tissues (pH 6.5) induces conformational changes of MFR protein on the nanoparticle surface, leading to a doxorubicin release rate of 89% within 48 hours;
  • Biological safety: The hemolysis rate of the nanoparticles is less than 1%, and no significant abnormalities are observed in liver and kidney function indicators of experimental mice at an administration dose of 5 mg/kg.
2.3.2.2 Therapeutic Application in Autoimmune Diseases

MFR-Fc fusion protein (molecular weight: ~90 kDa) is a novel biotherapeutic molecule for autoimmune diseases, whose triple action mechanism exerts a significant regulatory effect on the abnormal immune response:

  1. Competes with endogenous MFR for CD47 binding, blocking the inhibitory signal of macrophages and restoring the normal immune surveillance function;
  2. The Fc segment of the fusion protein binds to FcγRIIb on the surface of B cells, inhibiting the overproduction of autoantibodies;
  3. Preclinical validation: In a collagen-induced arthritis mouse model, the joint inflammation score of the MFR-Fc fusion protein administration group is reduced by 62% compared with the control group.

2.4 Frontier Research Challenges and Interdisciplinary Breakthroughs

Although MFR protein research has achieved fruitful results, it still faces challenges such as the complexity of its regulatory network, the diversity of cross-species functions and the difficulty of translational application. The interdisciplinary integration of synthetic biology, materials science and artificial intelligence has injected new innovative momentum into solving these scientific problems and achieved important breakthroughs.

In agricultural science, researchers have modified the MFR protein promoter into a plant disease biosensor based on the CRISPR-dCas9 system, realizing real-time and in-situ monitoring of plant pathogen infection, which provides a new technical means for early warning of crop diseases. In the biomedical field, bispecific antibodies designed based on the three-dimensional structure of MFR protein can simultaneously target CD47 and PD-L1 on the surface of tumor cells, which significantly enhances the anti-tumor immune response—preclinical models show that the complete tumor regression rate of this bispecific antibody is 3 times higher than that of single-target antibodies.

In addition, machine learning algorithms have accelerated the virtual screening of MFR protein variant libraries, greatly improving the efficiency of protein engineering modification. The MFR-9V mutant reported in 2024 has an affinity for CD47 optimized to 1.2 nM, which is a key breakthrough in the development of next-generation MFR-based immunotherapeutic drugs. The cryo-electron microscopy (cryo-EM) structure of the bispecific antibody binding to CD47 and PD-L1 on the tumor cell surface has been resolved, revealing the unique spatial conformation of the bispecific antibody for efficient dual-target recognition and binding at the molecular level.

High-resolution cryo-EM structure showing the binding mode of MFR-based bispecific antibody to CD47 and PD-L1 antigens on the tumor cell membrane, and the spatial interaction characteristics between the antibody and dual targets.

3. Research Significance of MFR Protein

MFR protein, as a multi-functional molecular target spanning animal and plant life processes, has far-reaching research significance in the fields of biomedicine, agricultural science and synthetic biology, and its in-depth study provides novel solutions for solving major scientific and practical problems.

  1. Uncovering the molecular mechanism of immune regulation: The study of MFR protein’s "Don't Eat Me" signal regulation mechanism enriches the understanding of the innate immune system’s recognition and regulation network, and clarifies the molecular mechanism of tumor immune escape, laying a theoretical foundation for the development of novel tumor immunotherapeutic strategies.
  2. Providing new targets for crop genetic improvement: The "molecular switch" regulatory mechanism of plant MFR protein in disease resistance and growth balance provides a key molecular target for crop molecular breeding, which is expected to solve the long-standing contradiction between crop disease resistance and yield, and promote the sustainable development of agricultural production.
  3. Driving the innovation of biotechnological tools: MFR protein-based research has spawned a series of innovative technical platforms such as prediction models, fluorescent proteins and detection kits, which not only improve the research efficiency of MFR protein itself, but also provide reusable technical tools for the research of other membrane proteins and signal pathways.
  4. Bridging biomedical and agricultural interdisciplinary research: MFR protein has divergent functions in animals and plants, and its research promotes the cross-fertilization of biomedical and agricultural science research methods and ideas, providing a typical case for the development of interdisciplinary life science research.
  5. Accelerating the translation of basic research to clinical and agricultural applications: The biotechnological innovations driven by MFR protein research (e.g., tumor-targeted nanoparticles, bispecific antibodies, crop disease resistance improvement) have shown excellent application potential in preclinical and agricultural experiments, and are expected to be translated into clinical drugs and new crop varieties in the near future, bringing tangible benefits to human health and food security.

4. ANT BIO PTE. LTD. Product Applications in MFR Protein Research

MFR protein research involves the detection of tyrosine phosphorylation, the identification of protein-protein interactions and the analysis of signal pathway regulation, which requires high-quality, high-specificity life science reagents to ensure the accuracy and reproducibility of experimental results. ANT BIO PTE. LTD. provides a series of specialized reagents through its Starter sub-brand (dedicated to antibodies), which are perfectly matched with the technical requirements of MFR protein research and provide solid experimental support for related research work.

4.1 Core Product Advantages for MFR Protein Research

The tyrosine phosphorylation modification of MFR protein is the core of its intracellular signal transduction (e.g., ITIM motif phosphorylation), and the detection and analysis of this modification is a key step in MFR protein functional research. ANT BIO PTE. LTD.’s Starter brand provides a variety of high-quality phosphotyrosine-specific antibodies and affinity purification beads, which have the following core advantages:

  1. High specificity: The recombinant antibodies specifically recognize phosphotyrosine residues, without cross-reaction with non-phosphorylated tyrosine and other phosphorylated amino acids, ensuring the accuracy of phosphorylation detection;
  2. High sensitivity: Can detect low-abundance phosphotyrosine modification of MFR protein, suitable for the analysis of weak signal pathway activation;
  3. Good batch consistency: Prepared by recombinant expression technology, the product performance of different batches is highly consistent, reducing experimental variability;
  4. Diverse application scenarios: Applicable to Western Blot, IP, Co-IP, ELISA and other experimental techniques commonly used in MFR protein research, meeting diverse experimental needs;
  5. Ready-to-use: The agarose beads conjugated with phosphotyrosine antibodies can be directly used for the affinity purification of phosphorylated MFR protein and its binding protein complex, simplifying the experimental operation process.

4.2 Product Application Scenarios in MFR Protein Research

  1. Detection of MFR protein phosphorylation: Starter brand phosphotyrosine recombinant antibodies can specifically detect the phosphorylation level of ITIM motif in MFR protein intracellular domain, and analyze the activation state of MFR-CD47 signal pathway under different experimental conditions (e.g., tumor cell co-culture, antibody intervention);
  2. Purification of phosphorylated MFR protein complex: Anti-Phosphotyrosine agarose beads can efficiently capture the phosphorylated MFR protein and its interacting protein complex (e.g., SHP-1/SHP-2) from cell lysates, providing a reliable method for the identification of MFR protein binding partners;
  3. Validation of MFR signal pathway regulation: Tyrosine Hydroxylase recombinant antibodies can be used as a control for tyrosine modification analysis, and combined with phosphotyrosine antibodies to verify the specificity of MFR protein tyrosine phosphorylation regulation, ensuring the reliability of experimental results;
  4. Development of MFR-CD47 detection kits: The high-specificity phosphotyrosine antibodies can be used as core detection reagents for the development of MFR-CD47 signal pathway detection kits, improving the sensitivity and specificity of the kit.

6. Related Product List for MFR Protein Research

All products are from the Starter sub-brand of ANT BIO PTE. LTD., with in-stock supply for most products and professional technical consultation available.

Catalog Number

Product Name

Product Parameters

Stock Status

Price

S0F0007

Anti-Phosphotyrosine agarose Beads

Conjugation: Agarose beads

In stock

Inquiry

S0B0319

Phosphotyrosine Recombinant Rabbit mAb (S-R207)

Host: Rabbit; Conjugation: Unconjugated

In stock

Inquiry

S0B0735

Phosphotyrosine Recombinant Mouse mAb (S-R433-2)

Host: Mouse; Conjugation: Unconjugated

In stock

Inquiry

S0B0749

Phosphotyrosine Recombinant Mouse mAb (S-R433-1)

Host: Mouse; Conjugation: Unconjugated

To be inquired

Inquiry

S0B0880

Tyrosine Hydroxylase Recombinant Rabbit mAb (S-1001-26)

Host: Rabbit; Conjugation: Unconjugated

To be inquired

Inquiry

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.